These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5216632)

  • 1. Utility of leukemogenic viruses for testing antiviral agents in vivo.
    Chirigos MA
    Ann N Y Acad Sci; 1965 Jul; 130(1):56-64. PubMed ID: 5216632
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. 3. AN IN VIVO ASSAY FOR ANTI-VIRAL AGENTS.
    CHIRIGOS MA
    Cancer Res; 1964 Jul; 24():1035-41. PubMed ID: 14198243
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular approaches to inhibit oncogenesis by RNA tumor viruses.
    Chandra P; Ebener U; Steel LK; Laube H; Gericke D; Mildner B; Bardos TJ; Ho YK; Götz A
    Ann N Y Acad Sci; 1977 Mar; 284():444-62. PubMed ID: 280144
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular targets of antiviral therapy.
    Crumpacker CS
    N Engl J Med; 1989 Jul; 321(3):163-72. PubMed ID: 2546077
    [No Abstract]   [Full Text] [Related]  

  • 5. [A model system for rapid screening of antiretroviral compounds].
    Shevelev AIa; Deianova OA; Goriunova LE; Zhukova AIu; Bibilashvili RSh
    Mol Biol (Mosk); 1995; 29(5):1114-25. PubMed ID: 8538606
    [No Abstract]   [Full Text] [Related]  

  • 6. Acyclic nucleoside phosphonates: a new dimension to the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    J Med Microbiol; 1998 Jan; 47(1):1-3. PubMed ID: 9449944
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral agents in the nineties.
    Sutherland DC
    Med J Aust; 1992 Jul; 157(2):135-8. PubMed ID: 1630378
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of E-5-(2-bromovinyl)-2'-deoxyuridine and other selective anti-herpes compounds on the induction of retrovirus particles in mouse BALB/3T3 cells.
    De Clercq E; Heremans H; Descamps J; Verhelst G; De Ley M; Billiau A
    Mol Pharmacol; 1981 Jan; 19(1):122-9. PubMed ID: 7207456
    [No Abstract]   [Full Text] [Related]  

  • 9. Report on an ICTV-sponsored symposium on Virus Evolution.
    Desselberger U
    Arch Virol; 2005 Mar; 150(3):629-35. PubMed ID: 15645372
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to antiretroviral drugs.
    Calvez V
    Antivir Ther; 1998; 3 Suppl 4():5-7. PubMed ID: 10723502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviruses and opportunistic infections--12th conference.
    Susman E
    IDrugs; 2005 Apr; 8(4):299-302. PubMed ID: 15800802
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.
    Shannon WM
    Ann N Y Acad Sci; 1977 Mar; 284():472-507. PubMed ID: 280146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviruses and opportunistic infections--12th conference--HAART.
    Susman E
    IDrugs; 2005 Apr; 8(4):303-5. PubMed ID: 15800803
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the cytotoxic and antiretroviral effects of 3-nitrosobenzamide and 4-iodo-3-nitrobenzamide.
    Chuang AJ; Killam KF; Chuang RY; Mendeleyev J; Kun E
    Proc West Pharmacol Soc; 1994; 37():117-9. PubMed ID: 7527151
    [No Abstract]   [Full Text] [Related]  

  • 15. Current report--HIV. Antiretroviral strategies.
    Goldschmidt RH; Legg JJ; Brossier KA
    J Am Board Fam Pract; 1993; 6(1):75-9. PubMed ID: 8421936
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models.
    Audigé A; Hofer U; Dittmer U; van den Broek M; Speck RF
    Viral Immunol; 2011 Oct; 24(5):375-85. PubMed ID: 21929334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-Docosanol inhibits in vitro replication of HIV and other retroviruses.
    Marcelletti JF; Lusso P; Katz DH
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):71-4. PubMed ID: 8825621
    [No Abstract]   [Full Text] [Related]  

  • 18. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of triazine analogues of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (cidofovir) and related compounds.
    Krecmerová M; Holý A; Pískala A; Masojídková M; Andrei G; Naesens L; Neyts J; Balzarini J; De Clercq E; Snoeck R
    J Med Chem; 2007 Mar; 50(5):1069-77. PubMed ID: 17298047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity.
    Krecmerová M; Holý A; Pohl R; Masojídková M; Andrei G; Naesens L; Neyts J; Balzarini J; De Clercq E; Snoeck R
    J Med Chem; 2007 Nov; 50(23):5765-72. PubMed ID: 17948980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.